240 related articles for article (PubMed ID: 33714856)
1. HBM4EU chromates study - Reflection and lessons learnt from designing and undertaking a collaborative European biomonitoring study on occupational exposure to hexavalent chromium.
Galea KS; Porras SP; Viegas S; Bocca B; Bousoumah R; Duca RC; Godderis L; Iavicoli I; Janasik B; Jones K; Knudsen LE; Leese E; Leso V; Louro H; Ndaw S; Ruggieri F; Sepai O; Scheepers PTJ; Silva MJ; Wasowicz W; Santonen T
Int J Hyg Environ Health; 2021 May; 234():113725. PubMed ID: 33714856
[TBL] [Abstract][Full Text] [Related]
2. Setting up a collaborative European human biological monitoring study on occupational exposure to hexavalent chromium.
Santonen T; Alimonti A; Bocca B; Duca RC; Galea KS; Godderis L; Göen T; Gomes B; Hanser O; Iavicoli I; Janasik B; Jones K; Kiilunen M; Koch HM; Leese E; Leso V; Louro H; Ndaw S; Porras SP; Robert A; Ruggieri F; Scheepers PTJ; Silva MJ; Viegas S; Wasowicz W; Castano A; Sepai O
Environ Res; 2019 Oct; 177():108583. PubMed ID: 31330491
[TBL] [Abstract][Full Text] [Related]
3. HBM4EU chromates study - Overall results and recommendations for the biomonitoring of occupational exposure to hexavalent chromium.
Santonen T; Porras SP; Bocca B; Bousoumah R; Duca RC; Galea KS; Godderis L; Göen T; Hardy E; Iavicoli I; Janasik B; Jones K; Leese E; Leso V; Louro H; Majery N; Ndaw S; Pinhal H; Ruggieri F; Silva MJ; van Nieuwenhuyse A; Verdonck J; Viegas S; Wasowicz W; Sepai O; Scheepers PTJ;
Environ Res; 2022 Mar; 204(Pt A):111984. PubMed ID: 34492275
[TBL] [Abstract][Full Text] [Related]
4. The HBM4EU chromates study - Outcomes and impacts on EU policies and occupational health practices.
Santonen T; Louro H; Bocca B; Bousoumah R; Duca RC; Fucic A; Galea KS; Godderis L; Göen T; Iavicoli I; Janasik B; Jones K; Leese E; Leso V; Ndaw S; Poels K; Porras SP; Ruggieri F; Silva MJ; Van Nieuwenhuyse A; Verdonck J; Wasowicz W; Tavares A; Sepai O; Scheepers PTJ; Viegas S
Int J Hyg Environ Health; 2023 Mar; 248():114099. PubMed ID: 36528954
[TBL] [Abstract][Full Text] [Related]
5. HBM4EU Chromates Study: Determinants of Exposure to Hexavalent Chromium in Plating, Welding and Other Occupational Settings.
Viegas S; Martins C; Bocca B; Bousoumah R; Duca RC; Galea KS; Godderis L; Iavicoli I; Janasik B; Jones K; Leese E; Leso V; Ndaw S; van Nieuwenhuyse A; Poels K; Porras SP; Ruggieri F; Silva MJ; Verdonck J; Wasowicz W; Scheepers PTJ; Santonen T; Hbm Eu Chromates Study Team
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329370
[TBL] [Abstract][Full Text] [Related]
6. Interlaboratory Comparison Investigations (ICIs) for human biomonitoring of chromium as part of the quality assurance programme under HBM4EU.
Nübler S; Schäfer M; Haji-Abbas-Zarrabi K; Marković S; Marković K; Esteban López M; Castaño A; Mol H; Koch HM; Antignac JP; Hajslova J; Thomsen C; Vorkamp K; Göen T
J Trace Elem Med Biol; 2022 Mar; 70():126912. PubMed ID: 34954563
[TBL] [Abstract][Full Text] [Related]
7. HBM4EU chromates study - the measurement of hexavalent and trivalent chromium in exhaled breath condensate samples from occupationally exposed workers across Europe.
Leese E; Jones K; Bocca B; Bousoumah R; Castaño A; Galea KS; Iavicoli I; López ME; Leso V; Ndaw S; Porras SP; Ruggieri F; Scheepers PTJ; Santonen T;
Toxicol Lett; 2023 Feb; 375():59-68. PubMed ID: 36535516
[TBL] [Abstract][Full Text] [Related]
8. HBM4EU chromates study - Usefulness of measurement of blood chromium levels in the assessment of occupational Cr(VI) exposure.
Ndaw S; Leso V; Bousoumah R; Rémy A; Bocca B; Duca RC; Godderis L; Hardy E; Janasik B; van Nieuwenhuyse A; Pinhal H; Poels K; Porras SP; Ruggieri F; Santonen T; Santos SR; Scheepers PTJ; Silva MJ; Verdonck J; Viegas S; Wasowicz W; Iavicoli I;
Environ Res; 2022 Nov; 214(Pt 1):113758. PubMed ID: 35764127
[TBL] [Abstract][Full Text] [Related]
9. Implementation of effect biomarkers in human biomonitoring studies: A systematic approach synergizing toxicological and epidemiological knowledge.
Rodríguez-Carrillo A; Mustieles V; Salamanca-Fernández E; Olivas-Martínez A; Suárez B; Bajard L; Baken K; Blaha L; Bonefeld-Jørgensen EC; Couderq S; D'Cruz SC; Fini JB; Govarts E; Gundacker C; Hernández AF; Lacasaña M; Laguzzi F; Linderman B; Long M; Louro H; Neophytou C; Oberemn A; Remy S; Rosenmai AK; Saber AT; Schoeters G; Silva MJ; Smagulova F; Uhl M; Vinggaard AM; Vogel U; Wielsøe M; Olea N; Fernández MF
Int J Hyg Environ Health; 2023 Apr; 249():114140. PubMed ID: 36841007
[TBL] [Abstract][Full Text] [Related]
10. How to use human biomonitoring in chemical risk assessment: Methodological aspects, recommendations, and lessons learned from HBM4EU.
Santonen T; Mahiout S; Alvito P; Apel P; Bessems J; Bil W; Borges T; Bose-O'Reilly S; Buekers J; Cañas Portilla AI; Calvo AC; de Alba González M; Domínguez-Morueco N; López ME; Falnoga I; Gerofke A; Caballero MDCG; Horvat M; Huuskonen P; Kadikis N; Kolossa-Gehring M; Lange R; Louro H; Martins C; Meslin M; Niemann L; Díaz SP; Plichta V; Porras SP; Rousselle C; Scholten B; Silva MJ; Šlejkovec Z; Tratnik JS; Joksić AŠ; Tarazona JV; Uhl M; Van Nieuwenhuyse A; Viegas S; Vinggaard AM; Woutersen M; Schoeters G
Int J Hyg Environ Health; 2023 Apr; 249():114139. PubMed ID: 36870229
[TBL] [Abstract][Full Text] [Related]
11. Application of human biomonitoring data to support policy development, raise awareness and environmental public health protection among countries within the HBM4EU project.
Ubong D; Stewart L; Sepai O; Knudsen LE; Berman T; Reynders H; Van Campenhout K; Katsonouri A; Van Nieuwenhuyse A; Ingelido AM; Castaño A; Pedraza-Díaz S; Eiríksdóttir ÁV; Thomsen C; Hartmann C; Gjorgjev D; De Felip E; Tolonen H; Santonen T; Klanova J; Norström K; Kononenko L; Silva MJ; Uhl M; Kolossa-Gehring M; Apel P; Jõemaa M; Jajcaj M; Estokova M; Luijten M; Lebret E; von Goetz N; Holcer NJ; Probst-Hensch N; Cavaleiro R; Barouki R; Tarroja E; Balčienė RM; Strumylaite L; Latvala S; Namorado S; Szigeti T; Ingi Halldorsson T; Olafsdottir K; Wasowicz W;
Int J Hyg Environ Health; 2023 Jun; 251():114170. PubMed ID: 37207539
[TBL] [Abstract][Full Text] [Related]
12. HBM4EU Occupational Biomonitoring Study on e-Waste-Study Protocol.
Scheepers PTJ; Duca RC; Galea KS; Godderis L; Hardy E; Knudsen LE; Leese E; Louro H; Mahiout S; Ndaw S; Poels K; Porras SP; Silva MJ; Tavares AM; Verdonck J; Viegas S; Santonen T; Hbm Eu E-Waste Study Team
Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948598
[TBL] [Abstract][Full Text] [Related]
13. Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessment.
Apel P; Rousselle C; Lange R; Sissoko F; Kolossa-Gehring M; Ougier E
Int J Hyg Environ Health; 2020 Sep; 230():113622. PubMed ID: 33045523
[TBL] [Abstract][Full Text] [Related]
14. Systematic review of biomonitoring data on occupational exposure to hexavalent chromium.
Verdonck J; Duca RC; Galea KS; Iavicoli I; Poels K; Töreyin ZN; Vanoirbeek J; Godderis L
Int J Hyg Environ Health; 2021 Jul; 236():113799. PubMed ID: 34303131
[TBL] [Abstract][Full Text] [Related]
15. HBM4EU feasibility studies: Lessons learned in combining health and human biomonitoring studies.
Elonheimo HM; Uusitalo K; Moore S; Andersson AM; Baber R; Wirkner K; David M; Kolossa-Gehring M; Stewart L; Sepai O; Lermen D; Bartel-Steinbach M; Rantakokko P; Koponen J; Tolonen H
Int J Hyg Environ Health; 2023 Mar; 248():114100. PubMed ID: 36508963
[TBL] [Abstract][Full Text] [Related]
16. Coordination of chemical analyses under the European Human Biomonitoring Initiative (HBM4EU): Concepts, procedures and lessons learnt.
Vorkamp K; Esteban López M; Gilles L; Göen T; Govarts E; Hajeb P; Katsonouri A; Knudsen LE; Kolossa-Gehring M; Lindh C; Nübler S; Pedraza-Díaz S; Santonen T; Castaño A
Int J Hyg Environ Health; 2023 Jun; 251():114183. PubMed ID: 37148759
[TBL] [Abstract][Full Text] [Related]
17. Is Urinary Chromium Specific to Hexavalent Chromium Exposure in the Presence of Co-exposure to Other Chromium Compounds? A Biomonitoring Study in the Electroplating Industry.
Martin Remy A; Robert A; Jacoby N; Wild P
Ann Work Expo Health; 2021 Apr; 65(3):332-345. PubMed ID: 33599259
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of effect as determined in human biomonitoring studies on hexavalent chromium and cadmium in the period 2008-2020.
Ventura C; Gomes BC; Oberemm A; Louro H; Huuskonen P; Mustieles V; Fernández MF; Ndaw S; Mengelers M; Luijten M; Gundacker C; Silva MJ
Environ Res; 2021 Jun; 197():110998. PubMed ID: 33713715
[TBL] [Abstract][Full Text] [Related]
19. PFASs: What can we learn from the European Human Biomonitoring Initiative HBM4EU.
Uhl M; Schoeters G; Govarts E; Bil W; Fletcher T; Haug LS; Hoogenboom R; Gundacker C; Trier X; Fernandez MF; Calvo AC; López ME; Coertjens D; Santonen T; Murínová ĽP; Richterová D; Brouwere K; Hauzenberger I; Kolossa-Gehring M; Halldórsson ÞI
Int J Hyg Environ Health; 2023 May; 250():114168. PubMed ID: 37068413
[TBL] [Abstract][Full Text] [Related]
20. Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for bisphenol A.
Ougier E; Zeman F; Antignac JP; Rousselle C; Lange R; Kolossa-Gehring M; Apel P
Environ Int; 2021 Sep; 154():106563. PubMed ID: 33894553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
